prednisolone has been researched along with B-Cell Chronic Lymphocytic Leukemia in 80 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We experienced a case of non-chronic lymphocytic leukemia type monoclonal B-cell lymphocytosis (MBL) that was exacerbated by increasing prednisolone for dermatomyositis and then improved by decreasing the dosage." | 8.02 | Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis. ( Hayashi, K; Kashiwakuma, D; Kubodera, A; Kume, A; Shimizu, R; Suzuki, Y; Tanaka, H, 2021) |
| " He was diagnosed as having fibrinoid syndrome and started on topical prednisolone, brimonidine, timolol-dorzolamide, and orally administered acetazolamide." | 4.98 | Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature. ( Hwang, CK; Kim, BJ; Kolomeyer, AM, 2018) |
| " We experienced a case of non-chronic lymphocytic leukemia type monoclonal B-cell lymphocytosis (MBL) that was exacerbated by increasing prednisolone for dermatomyositis and then improved by decreasing the dosage." | 4.02 | Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis. ( Hayashi, K; Kashiwakuma, D; Kubodera, A; Kume, A; Shimizu, R; Suzuki, Y; Tanaka, H, 2021) |
| " He was diagnosed with type I cryoglobulinemia and treated with rituximab, plasmapheresis, methylprednisolone, and ibrutinib was restarted." | 3.91 | Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL). ( Field, J; George, G; Singavi, A; Voshtina, E; Wright, N, 2019) |
| " Evans syndrome had been diagnosed and daily prednisolone therapy had been performed." | 3.68 | [Chronic lymphocytic leukemia diagnosed after corticosteroid therapy for Evans syndrome]. ( Iriuchijima, T; Matsuzaki, T; Mori, M; Murakami, H; Naruse, T; Shimizu, H; Tomioka, M; Yuasa, K, 1992) |
| "Of 79 evaluable patients, 58 (73%) had follicular lymphoma, 13 (16%) mantle cell lymphoma and 8 (10%) lymphoplasmacytic lymphoma." | 2.73 | Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group. ( Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M, 2007) |
| "There was no association of infections or febrile episodes with the use of corticosteroids or the CD4 count at the end of treatment and a poor correlation with the increase in CD4 counts during remission." | 2.69 | Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. ( Beran, M; Estey, E; Freireich, EJ; Kantarjian, H; Keating, MJ; Koller, C; Lerner, S; O'Brien, S; Robertson, LE, 1998) |
| "The ratio of minimal residual disease was 0." | 1.38 | [Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia]. ( Bozsó, T; Iványi, JL; Plander, M; Skrapits, J; Szendrei, T, 2012) |
| "Bendamustine is a safe and useful addition to the drug arsenal against lymphoproliferative disorders." | 1.37 | Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect. ( Ganesan, P; Malipatil, B; Sagar, TG; Sundersingh, S, 2011) |
| "Although renal failure due to leukemic infiltration has been described in many cases of acute leukemia, only 11 cases of renal failure due to CLL cells' infiltration have been described in the literature." | 1.36 | Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia. ( Brum, S; Carvalho, D; Carvalho, F; Ferreira, AC; Pataca, I; Santos, JR; Santos, MC, 2010) |
| "Paraneoplastic pemphigus is a rare autoimmune disease characterized by polymorphous mucocutaneous lesions in association with underlying neoplasia." | 1.36 | Paraneoplastic pemphigus characterized by polymorphic oral mucosal manifestations--report of two cases. ( Gao, Y; Hua, H; Yan, Z, 2010) |
| "Daunorubicin was the most potent drug." | 1.36 | Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin. ( Adam, E; Eksborg, S; Flaberg, E; Klein, E; Kozma, A; Markasz, L; Masszi, T; Miseta, A; Nagy, N; Otvos, R; Skribek, H; Szekely, L, 2010) |
| "Fifty-two cases of autoimmune hemolytic anemia (AHA) were observed within a series of 1203 patients (4." | 1.31 | Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. ( Cerretti, R; Coluzzi, S; Foa, R; Giannarelli, D; Girelli, G; Mandelli, F; Mauro, FR, 2000) |
| "Verapamil cytotoxicity was investigated in peripheral blood samples of 35 patients with B-cell CLL and 10 healthy control subjects." | 1.31 | Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro. ( Koski, T; Vilpo, J; Vilpo, L, 2000) |
| "In patients with chronic lymphocytic leukemia (CLL), TK levels may provide prognostic information independent of stage and other prognostic factors, but it is still unclear whether they can be used to predict the response to treatment and length of survival." | 1.31 | Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. ( Cacciola, E; Di Raimondo, F; Giustolisi, R; Kantarjian, H; Keating, MJ; Lerner, S; O'Brien, S, 2001) |
| "Muscle contraction was easily elicited by percussion, which was visible from the surface and propagated in a rolling manner." | 1.31 | Rippling muscle syndrome preceding malignant lymphoma. ( Ida, M; Kawagoe, S; Kojima, S; Takagi, A; Watanabe, T, 2002) |
| "There is a spectrum of types of MPGN seen in patients with CLL and there appears to be an association with the presence of monoclonal gammopathy." | 1.31 | Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases. ( Dwyer, KM; Firkin, F; Hill, PA; Lee, P; Murphy, BF, 2002) |
| "We describe a B cell chronic lymphocytic leukemia/lymphoma (B-CLL) patient with an adrenocortical adenoma." | 1.30 | Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder. ( Adachi, M; Adachi, Y; Fukushima, H; Hinoda, Y; Imai, K; Takahashi, T, 1997) |
| "Treatment with chlorambucil, prednisolone, and renal bed irradiation resulted in a substantial improvement in renal function which persisted until the the patient's death from marrow failure some eight years later." | 1.29 | Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia. ( Bass, PS; Davies, DR; Jones, NF; Majumdar, G; Pearson, TC; Phillips, JK, 1993) |
| "B-cell chronic lymphocytic leukemia (B-CLL) associated with bone marrow fibrosis is described." | 1.29 | Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis. ( Hyodo, H; Kimura, A; Kuramoto, A; Nakata, Y, 1993) |
| "We report a case of B-cell chronic lymphocytic leukemia in a 58 year old female in whom the clinical course was dominated by upper airway obstruction due to massive enlargement of the palatine and later the lingual tonsils." | 1.29 | Chronic lymphocytic leukaemia with upper airway obstruction. ( Cole, I; Cunningham, I; Dao, LP; Dean, MG; Mulligan S, P, 1996) |
| "Although many cases of Waldenström's macroglobulinemia (WMG) with pulmonary involvement have been reported, endobronchial involvement has not been described." | 1.28 | Endobronchial involvement with Waldenström's macroglobulinemia. ( Kanegae, H; Matumoto, I; Sakai, I; Shiroguchi, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.00) | 18.7374 |
| 1990's | 22 (27.50) | 18.2507 |
| 2000's | 27 (33.75) | 29.6817 |
| 2010's | 24 (30.00) | 24.3611 |
| 2020's | 3 (3.75) | 2.80 |
| Authors | Studies |
|---|---|
| Wright, N | 1 |
| Voshtina, E | 1 |
| George, G | 1 |
| Singavi, A | 1 |
| Field, J | 1 |
| Thermos, G | 1 |
| Tosios, KI | 1 |
| Inatsu, E | 1 |
| Fujii, K | 1 |
| Hatanaka, M | 1 |
| Okubo, A | 1 |
| Uchida, Y | 1 |
| Higashi, Y | 1 |
| Hiraki, T | 1 |
| Tanimoto, A | 1 |
| Kanekura, T | 1 |
| Kume, A | 1 |
| Kashiwakuma, D | 1 |
| Kubodera, A | 1 |
| Hayashi, K | 1 |
| Shimizu, R | 1 |
| Suzuki, Y | 2 |
| Tanaka, H | 1 |
| Tsertsvadze, T | 1 |
| Mitskevich, N | 1 |
| Bilanishvili, A | 1 |
| Girdaladze, D | 1 |
| Porakishvili, N | 1 |
| Sajawal, S | 1 |
| Mackie, SL | 1 |
| Hillmen, P | 1 |
| McGonagle, D | 1 |
| Koya, J | 1 |
| Ebisawa, K | 1 |
| Abe, H | 1 |
| Shinozaki-Ushiku, A | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Kolomeyer, AM | 1 |
| Hwang, CK | 1 |
| Kim, BJ | 1 |
| Sylvan, SE | 1 |
| Asklid, A | 1 |
| Johansson, H | 1 |
| Klintman, J | 1 |
| Bjellvi, J | 1 |
| Tolvgård, S | 1 |
| Kimby, E | 1 |
| Norin, S | 1 |
| Andersson, PO | 1 |
| Karlsson, C | 1 |
| Karlsson, K | 1 |
| Lauri, B | 1 |
| Mattsson, M | 1 |
| Sandstedt, AB | 1 |
| Strandberg, M | 1 |
| Österborg, A | 1 |
| Hansson, L | 1 |
| Scala, C | 1 |
| Ortiz, K | 1 |
| Nicolier, A | 1 |
| Briend-Marchal, A | 1 |
| Kiratli, H | 1 |
| Tarlan, B | 1 |
| Uzun, S | 1 |
| Tanas, Ö | 1 |
| Uner, A | 1 |
| Dharmshaktu, P | 1 |
| Gupta, N | 1 |
| Dhanwal, DK | 1 |
| Katagiri, S | 1 |
| Yoshizawa, S | 1 |
| Gotoh, M | 1 |
| Nakamura, I | 1 |
| Ohyashiki, K | 1 |
| Cramer, P | 1 |
| Isfort, S | 1 |
| Bahlo, J | 1 |
| Stilgenbauer, S | 1 |
| Döhner, H | 1 |
| Bergmann, M | 1 |
| Stauch, M | 1 |
| Kneba, M | 1 |
| Lange, E | 1 |
| Langerbeins, P | 1 |
| Pflug, N | 1 |
| Kovacs, G | 1 |
| Goede, V | 1 |
| Fink, AM | 1 |
| Elter, T | 1 |
| Fischer, K | 1 |
| Wendtner, CM | 1 |
| Hallek, M | 1 |
| Eichhorst, B | 1 |
| Del Principe, MI | 1 |
| Dal Bo, M | 1 |
| Bittolo, T | 1 |
| Buccisano, F | 1 |
| Rossi, FM | 1 |
| Zucchetto, A | 1 |
| Rossi, D | 1 |
| Bomben, R | 1 |
| Maurillo, L | 1 |
| Cefalo, M | 1 |
| De Santis, G | 1 |
| Venditti, A | 1 |
| Gaidano, G | 1 |
| Amadori, S | 1 |
| de Fabritiis, P | 1 |
| Gattei, V | 1 |
| Del Poeta, G | 1 |
| Jayasekera, PS | 1 |
| Bakshi, A | 1 |
| Al-Sharqi, A | 1 |
| Lim, SM | 1 |
| Jang, JW | 1 |
| Kim, BW | 1 |
| Choi, H | 1 |
| Choi, KY | 1 |
| Park, SJ | 1 |
| Han, CW | 1 |
| Lindhagen, E | 2 |
| Norberg, M | 1 |
| Kanduri, M | 1 |
| Tobin, G | 2 |
| Säisänen, L | 1 |
| Aberg, M | 1 |
| Gustafsson, MG | 1 |
| Sundström, C | 2 |
| Rosenquist, R | 2 |
| Aleskog, A | 2 |
| Ferreira, AC | 1 |
| Brum, S | 1 |
| Carvalho, D | 1 |
| Pataca, I | 1 |
| Carvalho, F | 1 |
| Santos, MC | 1 |
| Santos, JR | 1 |
| Namdar, T | 1 |
| Mailänder, P | 1 |
| Lange, T | 1 |
| Anoop, P | 1 |
| Stanford, M | 1 |
| Saso, R | 1 |
| Dearden, CE | 1 |
| Graves, TD | 1 |
| Collins, GP | 1 |
| Parry, A | 1 |
| Yan, Z | 1 |
| Hua, H | 1 |
| Gao, Y | 1 |
| Skribek, H | 1 |
| Otvos, R | 1 |
| Flaberg, E | 1 |
| Nagy, N | 1 |
| Markasz, L | 1 |
| Eksborg, S | 1 |
| Masszi, T | 1 |
| Kozma, A | 1 |
| Adam, E | 1 |
| Miseta, A | 1 |
| Klein, E | 1 |
| Szekely, L | 1 |
| Sillito, F | 1 |
| Cervi, P | 2 |
| Skibinska, M | 1 |
| Tadmor, T | 1 |
| Bejar, J | 1 |
| Attias, D | 1 |
| Polliack, A | 1 |
| Malipatil, B | 1 |
| Ganesan, P | 1 |
| Sundersingh, S | 1 |
| Sagar, TG | 1 |
| Krejci, M | 1 |
| Doubek, M | 1 |
| Brychtova, Y | 1 |
| Stehlikova, O | 1 |
| Chovancova, J | 1 |
| Tichy, B | 1 |
| Francova, HS | 1 |
| Navratil, M | 1 |
| Tomiska, M | 1 |
| Horky, O | 1 |
| Pospisilova, S | 1 |
| Mayer, J | 1 |
| Plander, M | 1 |
| Skrapits, J | 1 |
| Bozsó, T | 1 |
| Szendrei, T | 1 |
| Iványi, JL | 1 |
| McCurdy, O | 1 |
| McCormack, C | 1 |
| Ritchie, D | 1 |
| Prince, HM | 1 |
| Brown, SJ | 1 |
| Barrett, PD | 1 |
| Hendrick, A | 1 |
| Langtry, JA | 1 |
| Aktan, M | 1 |
| Akkaya, A | 1 |
| Doğan, O | 1 |
| Dincol, G | 1 |
| BRUNNER, K | 1 |
| KEISER, G | 1 |
| MARTZ, G | 1 |
| SCHREK, R | 1 |
| Fujino, Y | 1 |
| Sawamura, S | 1 |
| Kurakawa, N | 1 |
| Hisasue, M | 1 |
| Masuda, K | 1 |
| Ohno, K | 1 |
| Tsujimoto, H | 1 |
| Laurell, A | 1 |
| Thunberg, U | 1 |
| Roos, G | 1 |
| Nilsson, K | 1 |
| Nygren, P | 1 |
| Höglund, M | 1 |
| Larsson, R | 1 |
| Ayyildiz, O | 1 |
| Isikdogan, A | 1 |
| Bolaman, Z | 1 |
| Muftuoglu, E | 1 |
| Narayan, H | 1 |
| Bandyopadhyay, D | 1 |
| Schmidt, K | 1 |
| Chachlani, N | 1 |
| Hughes, M | 1 |
| Paneesha, S | 1 |
| Rose, P | 1 |
| Borg, A | 1 |
| Nishida, H | 1 |
| Murase, T | 1 |
| Ueno, H | 2 |
| Park, JW | 1 |
| Yano, T | 1 |
| Ikeda, Y | 1 |
| Hanamura, A | 1 |
| Hayakawa, M | 1 |
| Naito, K | 1 |
| Nickenig, C | 1 |
| Dreyling, M | 1 |
| Hoster, E | 1 |
| Ludwig, WD | 1 |
| Dörken, B | 1 |
| Freund, M | 1 |
| Huber, C | 1 |
| Ganser, A | 1 |
| Trümper, L | 1 |
| Forstpointner, R | 1 |
| Unterhalt, M | 1 |
| Hiddemann, W | 1 |
| Nanda, M | 1 |
| Nanda, A | 1 |
| Al-Sabah, H | 1 |
| Dvorak, R | 1 |
| Alsaleh, QA | 1 |
| Helbling, I | 1 |
| Walewska, R | 1 |
| Dyer, MJ | 1 |
| Bamford, M | 1 |
| Harman, KE | 1 |
| Smolej, L | 1 |
| Hasselbach, HC | 1 |
| Fickenscher, H | 1 |
| Nölle, B | 1 |
| Roider, J | 1 |
| Lavabre-Bertrand, T | 1 |
| Exbrayat, C | 1 |
| Bourquard, P | 1 |
| Lavabre-Bertrand, C | 1 |
| Fégueux, N | 1 |
| Poncelet, P | 1 |
| Rousset, T | 1 |
| Taïb, J | 1 |
| Emberger, JM | 1 |
| Navarro, M | 1 |
| Bosanquet, AG | 2 |
| McCann, SR | 1 |
| Crotty, GM | 1 |
| Mills, MJ | 2 |
| Catovsky, D | 1 |
| Hirano, T | 1 |
| Tomiyoshi, K | 1 |
| Take, H | 1 |
| Watanabe, N | 1 |
| Oriuchi, N | 1 |
| Inoue, T | 1 |
| Naruse, M | 1 |
| Endo, K | 1 |
| Phillips, JK | 1 |
| Bass, PS | 1 |
| Majumdar, G | 2 |
| Davies, DR | 1 |
| Jones, NF | 1 |
| Pearson, TC | 1 |
| Kimura, A | 1 |
| Hyodo, H | 1 |
| Nakata, Y | 1 |
| Kuramoto, A | 1 |
| Taillan, B | 1 |
| Garnier, G | 1 |
| Heudier, P | 1 |
| Pesce, A | 1 |
| Fuzibet, JG | 1 |
| Dujardin, P | 1 |
| Ando, S | 2 |
| Otani, N | 1 |
| Kanbe, T | 1 |
| Brown, S | 1 |
| Slater, NG | 1 |
| Singh, AK | 1 |
| Hattenhauer, MG | 1 |
| Pach, JM | 1 |
| Dean, MG | 1 |
| Cunningham, I | 1 |
| Dao, LP | 1 |
| Cole, I | 1 |
| Mulligan S, P | 1 |
| Ruskoné-Fourmestraux, A | 1 |
| Delmer, A | 1 |
| Lavergne, A | 1 |
| Molina, T | 1 |
| Brousse, N | 1 |
| Audouin, J | 1 |
| Rambaud, JC | 1 |
| Levin, M | 1 |
| Aziz, M | 1 |
| Opitz, L | 1 |
| Adachi, Y | 1 |
| Adachi, M | 1 |
| Hinoda, Y | 1 |
| Fukushima, H | 1 |
| Takahashi, T | 1 |
| Imai, K | 1 |
| Yokose, N | 1 |
| Ogata, K | 1 |
| Nakamura, K | 1 |
| Kamikubo, K | 1 |
| Tamura, H | 1 |
| An, E | 1 |
| Dan, K | 1 |
| Nomura, T | 1 |
| Drake, WM | 1 |
| Monson, JP | 1 |
| Trainer, PJ | 1 |
| Sharief, M | 1 |
| Dick, JP | 1 |
| Kelsey, SM | 2 |
| Keating, MJ | 2 |
| O'Brien, S | 2 |
| Lerner, S | 2 |
| Koller, C | 1 |
| Beran, M | 1 |
| Robertson, LE | 1 |
| Freireich, EJ | 1 |
| Estey, E | 1 |
| Kantarjian, H | 2 |
| Bosanquet, MI | 1 |
| Takahashi, F | 1 |
| Ogawa, Y | 1 |
| Hasebe, N | 1 |
| Natori, S | 1 |
| Tokusashi, Y | 1 |
| Miyokawa, N | 1 |
| Kikuchi, K | 1 |
| Mauro, FR | 1 |
| Foa, R | 1 |
| Cerretti, R | 1 |
| Giannarelli, D | 1 |
| Coluzzi, S | 1 |
| Mandelli, F | 1 |
| Girelli, G | 1 |
| Várkonyi, J | 1 |
| Zalatnai, A | 1 |
| Timár, J | 1 |
| Matolcsi, A | 1 |
| Falus, A | 1 |
| Bencsáth, M | 1 |
| László, V | 1 |
| Pócsik, E | 1 |
| Kotlán, B | 1 |
| Császár, A | 1 |
| Vilpo, J | 1 |
| Koski, T | 1 |
| Vilpo, L | 1 |
| Hall, RL | 1 |
| Leahy, MF | 1 |
| Cobcroft, R | 1 |
| Di Raimondo, F | 1 |
| Giustolisi, R | 1 |
| Cacciola, E | 1 |
| McBride, NC | 1 |
| Cavenagh, JD | 1 |
| Ward, MC | 1 |
| Grant, I | 1 |
| Schey, S | 1 |
| Gray, A | 1 |
| Hughes, A | 1 |
| Newland, AC | 1 |
| Takagi, A | 1 |
| Kojima, S | 1 |
| Watanabe, T | 1 |
| Ida, M | 1 |
| Kawagoe, S | 1 |
| Hill, PA | 1 |
| Firkin, F | 1 |
| Dwyer, KM | 1 |
| Lee, P | 1 |
| Murphy, BF | 1 |
| Sakai, I | 1 |
| Shiroguchi, T | 1 |
| Kanegae, H | 1 |
| Matumoto, I | 1 |
| Tomioka, M | 1 |
| Shimizu, H | 1 |
| Matsuzaki, T | 1 |
| Yuasa, K | 1 |
| Iriuchijima, T | 1 |
| Mori, M | 1 |
| Murakami, H | 1 |
| Naruse, T | 1 |
| Murphy, JA | 1 |
| Pitts, JF | 1 |
| Dudgeon, J | 1 |
| Hogg, RB | 1 |
| Harnett, AN | 1 |
| Muraoka, A | 1 |
| Asami, M | 1 |
| Yoneda, R | 1 |
| Ogura, M | 1 |
| Oribe, T | 1 |
| Suzuki, K | 1 |
| Maeda, M | 1 |
| Chinzei, T | 1 |
| Yamashiro, K | 1 |
| Ijichi, S | 1 |
| Sano, Y | 1 |
| Une, F | 1 |
| Maruyama, I | 1 |
| Osame, M | 1 |
| Weiss, C | 1 |
| Ho, AD | 1 |
| Hiller, E | 1 |
| Thiel, E | 1 |
| Schlag, R | 1 |
| Lipp, T | 1 |
| Herrmann, R | 1 |
| Musch, E | 1 |
| Termander, B | 1 |
| Hunstein, W | 1 |
| Hansen, MM | 1 |
| Andersen, E | 1 |
| Christensen, BE | 1 |
| Christiansen, I | 1 |
| Geisler, C | 1 |
| Kristensen, D | 1 |
| Jensen, KB | 1 |
| Junker, P | 1 |
| Jootar, S | 1 |
| Nitiyanant, P | 1 |
| Ratanaprakarn, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance[NCT01723839] | Phase 2 | 21 participants (Actual) | Interventional | 2012-02-22 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Analysis of the Primary Endpoint: The complete responses will be estimated by the number of patients with CR divided by the total number of evaluable patients. (NCT01723839)
Timeframe: 28 day cycle, up to 4 cycles
| Intervention | Percentage of Participants (Number) |
|---|---|
| FCR With Lenalidomide | 45 |
Analysis of the other Secondary Endpoints: The overall response rate will be estimated by the number of patients with complete and partial responses divided by the total number of evaluable patients. (NCT01723839)
Timeframe: 28 day cycle, up to 6 cycles
| Intervention | Percentage of Participants (Number) |
|---|---|
| FCR With Lenalidomide | 95 |
2 reviews available for prednisolone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.
Topics: Adenine; Administration, Topical; Aged; Anterior Chamber; Antihypertensive Agents; Antineoplastic Ag | 2018 |
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II a | 2015 |
8 trials available for prednisolone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydroch | 2019 |
Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antin | 2013 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophospham | 2007 |
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; C | 1995 |
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 1998 |
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2001 |
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness.
Topics: Adult; Aged; Aged, 80 and over; Chlorambucil; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell | 1990 |
CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as Topic; | 1988 |
70 other studies available for prednisolone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).
Topics: Adenine; Aged; Cryoglobulinemia; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; | 2019 |
Ibrutinib-associated oral ulcers.
Topics: Adenine; Aged; Combined Modality Therapy; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Metr | 2020 |
Epstein-Barr virus-positive mucocutaneous ulcer in a patient with untreated chronic lymphocytic leukemia and hypogammaglobulinemia.
Topics: Agammaglobulinemia; Aged; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Epstein-Barr Virus In | 2020 |
Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis.
Topics: B-Lymphocytes; Dermatomyositis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytosis; Predn | 2021 |
PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Case-Control | 2017 |
Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.
Topics: Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; | 2017 |
Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antigens, CD; Antineoplastic Combined Chemotherapy | 2018 |
Lymphocytic leukemia in a captive dhole (Cuon alpinus).
Topics: Animals; Canidae; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Prednisolone | 2013 |
Orbital richter syndrome.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, | 2013 |
Successful treatment of acquired pure red cell aplasia with oral corticosteroids in a patient with B-cell CLL.
Topics: Administration, Oral; Adrenal Cortex Hormones; Bone Marrow; Diagnosis, Differential; Humans; Leukemi | 2013 |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
Topics: Amikacin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Hu | 2014 |
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X P | 2016 |
Eosinophilic dermatosis of haematological malignancy.
Topics: Administration, Oral; Eosinophilia; Glucocorticoids; Hematologic Neoplasms; Humans; Leukemia, Lympho | 2016 |
[Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Hepatitis B; Hepatitis B | 2008 |
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Case-Control Studies; Chromosome Deletion; Ch | 2009 |
Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Kidney; Leukemia, | 2010 |
[MRSA infection of the hand in immunodeficient patients].
Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Antineoplastic Agents, Hormonal; Combined Modalit | 2009 |
Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2010 |
Richter's syndrome of the brain and the spinal cord.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv | 2011 |
Paraneoplastic pemphigus characterized by polymorphic oral mucosal manifestations--report of two cases.
Topics: Aged; Diagnosis, Differential; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody | 2010 |
Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cluster Analysis; Daunorubicin; Doxorubi | 2010 |
Something fishy in the immunocompromised.
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Fatal Outcome; | 2011 |
Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2011 |
Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Bendamustine | 2011 |
[Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival | 2012 |
Exacerbation of lymphomatoid papulosis during rituximab therapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2014 |
Subcorneal pustular dermatosis in association with chronic lymphocytic leukaemia.
Topics: Aged; Axilla; Diagnosis, Differential; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Predn | 2003 |
Chronic lymphocytic leukemia and multiple myeloma in the same patient: case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Neoplasms; Chlorambucil; C | 2003 |
[Corticosteroid therapy of chronic lymphatic leukemia].
Topics: Adrenal Cortex Hormones; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoi | 1963 |
PREDNISOLONE SENSITIVITY AND CYTOLOGY OF VIABLE LYMPHOCYTES AS TESTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA.
Topics: Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphocytes; Lymphocyt | 1964 |
Treatment of chronic lymphocytic leukaemia in three dogs with melphalan and prednisolone.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood Cell Count; Blood Chemical Analysis; Blood Platele | 2004 |
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cladribine; Cyclophosphamide; Cytarab | 2004 |
Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Chlorambucil; Female; Follow-U | 2004 |
Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Co | 2005 |
Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Mu | 2006 |
[Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2005 |
Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone.
Topics: Desmoglein 3; Fluorescent Antibody Technique; Glucocorticoids; Hepatitis C; Humans; Immunoglobulins, | 2007 |
Erythema annulare centrifugum associated with chronic lymphocytic leukaemia.
Topics: Aged; Erythema; Female; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisolon | 2007 |
Why R-CHOP for first line treatment of chronic lymphocytic leukemia?
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Co | 2007 |
[Atypical ocular toxoplasmosis with concomitant ocular reactivation of varicella-zoster virus and cytomegalovirus in an immunocompromised host].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Chlorambucil; Chorioretinitis; Como | 2008 |
CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone | 1994 |
Reversible functional asplenia. Autoimmune hemolytic anemia with thrombocytopenia in chronic lymphocytic leukemia.
Topics: Anemia, Hemolytic, Autoimmune; Erythrocytes; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; | 1994 |
Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia.
Topics: Chlorambucil; Combined Modality Therapy; Humans; Kidney; Kidney Failure, Chronic; Leukemia, Lymphocy | 1993 |
Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Division; Cells, Cul | 1993 |
[Erythroblastopenia in chronic lymphoid leukemia: value of corticoids-cyclosporine combination].
Topics: Cyclosporine; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mid | 1993 |
[A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration S | 1993 |
Clinical spectrum of autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Azathioprine; Chlorambucil; Cyclophosphamide; Drug Therapy, Com | 1993 |
Ocular lymphoma in a patient with chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biopsy; Combined Modality Therapy; Eye Neo | 1996 |
Chronic lymphocytic leukaemia with upper airway obstruction.
Topics: Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; | 1996 |
Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs.
Topics: Adult; Aged; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bioma | 1997 |
Steroid-responsive interstitial pneumonitis after fludarabine therapy.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Cough; Fatal Outcome; Glucocorticoids; Humans | 1997 |
Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined C | 1997 |
Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemia.
Topics: Afibrinogenemia; Anemia, Hemolytic, Autoimmune; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 1997 |
Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Demy | 1998 |
Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Chlorambucil; Cladribine; Comorb | 2000 |
Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Enala | 2000 |
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.
Topics: Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protoco | 2000 |
Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Histidi | 2000 |
Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member | 2000 |
Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Azathiop | 2001 |
Pure red cell aplasia associated with small lymphocytic lymphoma.
Topics: Anemia, Aplastic; B-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Drug Therapy, Combina | 2001 |
Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Female; Humans; Leu | 2001 |
Rippling muscle syndrome preceding malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Electromyography; Hyp | 2002 |
Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
Topics: Adult; Aged; Antineoplastic Agents; Chlorambucil; Drug Therapy, Combination; Female; Glomerular Mesa | 2002 |
Endobronchial involvement with Waldenström's macroglobulinemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Cyclophosphamide; Dyspnea | 1992 |
[Chronic lymphocytic leukemia diagnosed after corticosteroid therapy for Evans syndrome].
Topics: Anemia, Hemolytic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymphocy | 1992 |
Retinal detachments due to chronic lymphocytic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Humans; Leu | 1991 |
[B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; D | 1990 |
[Accessory use of protease-inhibiting agents for disease remission in a patient with autoimmune hemolytic anemia associated with B-CLL].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Benzamidines; Complement Activation; Complement Inactivator Pro | 1990 |
Angioimmunoblastic lymphadenopathy with dysproteinemia in Thailand.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dysgammaglobulinemia; | 1987 |